S&P 500 (NYSE:SPY) component C. R. Bard, Inc. (NYSE:BCR) reported its results for the first quarter. C.R. Bard, Inc. designs, manufactures and sells diagnostic, medical, surgical and patient care devices.
C. R. Bard Earnings Cheat Sheet for the First Quarter
Results: Net income for the medical instruments and supplies company rose to $131.9 million ($1.49/share) vs. $120.9 million ($1.24/share) YoY. A rise of 9.1% from the year earlier quarter.
Revenue: Rose 7.6% to $700.3 million YoY.
Actual vs. Wall St. Expectations: BCR (NYSE:BCR) beat the mean analyst estimate of $1.46/share. Estimates ranged from $1.44 per share to $1.48 per share.
Quoting Management: Timothy M. Ring, chairman and chief executive officer, commented, “Through the strength of our diversified portfolio, we delivered strong revenue and earnings growth again this quarter, despite the fact that we saw no measurable improvement in hospital volumes and procedures. This success demonstrates the effectiveness of our product leadership strategy and the ability of our organization to execute. Our R&D investments and business development activities continue to provide healthy returns to shareholders.”
Key Stats: Net income has increased 10.9% year over year on average across the last five quarters. The biggest gain came in the fourth of the last fiscal year, when income climbed 28.6% from the year earlier quarter.
Over the last five quarters, revenue has increased 7.4% on average year over year. The biggest increase came in the first quarter of the last fiscal year, when revenue rose 9.1% from the year earlier quarter.
Competitors to Watch: Teleflex Incorporated (NYSE:TFX), Covidien plc (NYSE:COV), Boston Scientific Corp. (NYSE:BSX), Merit Medical Systems, Inc. (NASDAQ:MMSI), AngioDynamics, Inc. (NASDAQ:ANGO), Angiotech Pharmaceuticals, Inc. (NYSE:USA) (NASDAQ:ANPI), Theragenics Corporation (NYSE:TGX), Rochester Medical Corp. (NASDAQ:ROCM), CONMED Corporation (NASDAQ:CNMD), and Becton, Dickinson and Co. (NYSE:BDX).
Today’s Performance: Shares of BCR (NYSE:BCR) are trading at $104.30 as of April 21, 2011 at 4:34 PM ET, up 1.2% from the previous closing price of $103.07.